Insilico Medicine

Visit Website
 Insilico Medicine

Description

️ 🖼Tool name: Insilico Medicine
🔖 Tool Category: Applied Prediction and Machine Learning / Analytics and Dashboards / Prediction and Drug Development

️ ✏What does this tool offer?
The Insilico Medicine platform provides an end-to-end solution for drug discovery and design using artificial intelligence. The platform includes key engines such as PandaOmics for analyzing biological data and scientific texts to discover therapeutic targets, and Chemistry42 for generating and optimizing drug molecules. The tool aims to accelerate the R&D process, reduce costs, and improve the quality of drugs before they enter clinical trials.

What does it actually offer based on user experience?

  • Discover new therapeutic targets by analyzing genomic data, laboratory experiments, and scientific texts.

  • Generate optimized and AI-generated drug molecules with predicted efficacy and toxicity.

  • Reduce drug discovery time from years to months.

  • Integrate biological analysis, computational chemistry, and textual data modeling into a single platform.

🤖 Does it involve automation?
Yes, all stages of analysis and generation are automated:

  • Analyze omics data and extract targets.

  • Generation and optimization of drug molecules via physical simulation and ADMET.

  • Prioritization and presentation of results in the form of reports and charts ready for research or presentation.

💰 Pricing model:

  • No public free version has been announced; the tool is intended for companies and research institutions.

  • Paid plans are based on data volume, number of projects, and platform customization (Enterprise/Corporate Licensing).

🧭 How to access the tool:

  • Contact Insilico Medicine's sales or support team to register an organizational account.

  • Access via a cloud-based platform or internal integration within a research organization.

🔗 Trial link or official website: Insilico Medicine

Pricing Details

No public free version has been announced; the tool is intended for companies and research institutions. Paid plans depend on data volume, number of projects, and platform customization (Enterprise/Corporate Licensing).